Ametek (AME) came out with quarterly earnings of $1.89 per share, beating the Zacks Consensus Estimate of $1.76 per share. This compares to earnings of $1.66 per share a year ago.
Besides Wall Street's top-and-bottom-line estimates for Ametek (AME), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Here, we have picked four technology stocks, META, RDDT, IDCC and AME, which are likely to pull off earnings surprises in the third quarter of 2025.
Ametek (AME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
From advanced alloys to bioprinting breakthroughs, 3D Printing leaders like AMETEK, CRS, ATI, and DDD are shaping the future of additive manufacturing.
Ametek (AME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Electronics -Testing Equipment industry players, such as AME and ITRI, are poised to benefit from the solid demand for testing instruments.
Review Ametek's (AME) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
AMETEK, Inc. (NYSE:AME ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Dalip Mohan Puri - Executive VP & CFO David A. Zapico - Chairman of the Board & CEO Kevin C.
While the top- and bottom-line numbers for Ametek (AME) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Ametek (AME) came out with quarterly earnings of $1.78 per share, beating the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $1.66 per share a year ago.
I am upgrading AMETEK to a 'Buy' with a $199 price target, anticipating an earnings surprise despite negative analyst sentiment. Aerospace, defense, and power markets may provide strong tailwinds, while industrials and medical devices are set for recovery as inventory digestion winds down. Recent acquisitions, robust US/EU industrial investments, and macroeconomic certainty from tariff policy position AME for moderate growth in FY25 and beyond.